David Riseberg Profile Image

Chief, Division of Medical Oncology and Hematology

Specialty:

  • Medical Oncology and Hematology

Board Certifications:

  • Medical Oncology
  • Hematology

Languages:

  • English

Areas of Interest:

  • Breast Cancer, Blood Disorders

Locations:

  • The Weinberg Center at Mercy
  • Mercy Personal Physicians at Glen Burnie
  • Mercy Personal Physicians at Lutherville

David Riseberg, M.D.

David A. Riseberg, M.D., is Chief of Medical Oncology and Hematology at Mercy Medical Center in Baltimore, Maryland. Dr. Riseberg is a top rated oncologist who is Board Certified in Medical Oncology and Hematology. Dr. Riseberg is a highly regarded specialist treating patients with many types of cancers and blood disorders including breast cancer, colon and rectal cancer, gynecologic cancers, lung cancer, leukemia and lymphoma.

Leadership in Oncology

In addition to his role as Chief, Dr. Riseberg is Chair of The Cancer Committee at Mercy Medical Center. In these leadership roles, Dr. Riseberg deliberates with other cancer experts to design and develop care paths for complex cancer cases. This team of cancer surgeons and specialists also invests time, energy and resources to design standards of care that elevate the patient experience and clinical outcomes.

Dedicated to Breast Cancer Research and Treatment

Dr. David Riseberg has dedicated and focused much of his medical career on the research and treatment of breast cancer. His continued dedication to helping women face this life changing disease is a commitment that has translated into research, outreach and a better understanding of how to manage the disease and care for breast cancer patients. 

Dr. Riseberg works together with the surgeons, certified nurse practitioners and nurses in The Breast Center at Mercy to help women get a coordinated and comprehensive treatment plan and, when appropriate, enrolled as a participant in a current clinical trial. This approach allows the patient to benefit from the collective wisdom, experience and knowledge of the medical team.

Utilizing the latest chemotherapy treatments and in collaboration with top rated oncologists and radiation specialists within Mercy’s Institute for Cancer Care, Dr. Riseberg helps women face the challenges and triumphs of a breast cancer diagnosis.

Experienced Oncologist in Treating Leukemia and Lymphoma

Dr. David Riseberg is equally as gifted in his knowledge and first-hand experience in treating blood disorders, leukemia and lymphoma. Sometimes, because these diagnoses do not have the word cancer in their name people feel these are less severe disorders. In fact, many blood disorders are cancerous and can have devastating results if not effectively treated. Turning to a skilled medical oncologist like Dr. Riseberg is one of the best ways to evaluate the stage of the blood disorder and then determine the best available treatment options.

Recognized as a Leading Medical Oncologist

Dr. David Riseberg is a highly respected medical oncologist within the Baltimore area. He has been recognized by Baltimore magazine as one of the areas “Top Doctors,” a distinction awarded by his peers within the medical community.

Dr. Riseberg is caring, friendly, interested in the lives of his patients and their families and an extremely visible doctor in Mercy’s Outpatient Chemotherapy patient suite. He visits with patients, making sure their medical needs are met and their personal comforts are given individualized attention.

The genuine and heartfelt appreciation for his compassionate care and bedside manner has been voiced by Dr. Riseberg’s patients in a particularly special and touching way. On multiple occasions Dr. Riseberg has earned the “Compassionate Doctor Recognition” – as voted by his patients. He also has been honored as the recipient of the “Patients’ Choice Award.”

Education & Fellowships
  • Fellowship  – Clinical Associate, Medicine Branch, National Cancer Institute of the National Institutes of Health
  • Residency – University of Maryland Medical System
  • Medical Degree – University of Maryland Medical System

Associations & Memberships
  • American Society of Clinical Oncology
  • American Society of Hematology
  • American Medical Association

Tamoxifen for Breast Cancer - Dr. David Riseberg - Mercy

Mercy Medical Center's Dr. David Riseberg discusses the benefits of the drug, Tamoxifen, when treating women with breast cancer. Learn more at mdmercy.com.

Avoiding Chemotherapy in Early Breast Cancer - Dr. David Riseberg - Mercy

Mercy oncologist Dr. David Riseberg discusses a new test that is used to indicate if chemotherapy is needed in the treatment of breast cancer. Learn more at mdmercy.com.

New Breast Cancer Medications for Advanced Breast Cancer - Dr. David Riseberg - Mercy

Mercy’s Dr. David Riseberg discusses a new class of breast cancer medications for women with advanced breast cancer. Learn more at mdmercy.com.

Don't Put Off Cancer Screenings for Fear of Coronavirus - Dr. David Riseberg - Mercy

Dr. David Riseberg discusses the importance of resuming regular cancer screenings even during the pandemic. Learn more at mdmercy.com.

Cancer Patients Have Risks Associated with Coronavirus - Dr. David Riseberg - Mercy

Dr. David Riseberg discusses the increased risk cancer patients have with coronavirus. Learn more at mdmercy.com.

The Latest Breast Cancer Therapies - Dr. David Riseberg - Mercy

Mercy Medical Center oncologist Dr. David Riseberg discusses the latest adjuvant breast cancer therapies. Learn more at mdmercy.com.

Dealing with Breast Cancer Fatigue - Dr. David Riseberg - Mercy

Dr. David Riseberg discusses ways for breast cancer patients to help reduce fatigue. Learn more at mdmercy.com

Using a Cooling Cap to Reduce Hair Loss During Chemo - Dr. David Riseberg - Mercy

Dr. David Riseberg, Chief of Medical Oncology and Hematology at Mercy, discusses the use of cooling caps to reduce hair loss during chemotherapy. Learn more at mdmercy.com.

Locations

Insurances Accepted

See a list of insurances accepted at Mercy. Restrictions may apply. Patients should confirm coverage with their carrier prior to appointment date.